- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02721082
Changing the Default for Tobacco Treatment
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
In many health conditions, the default treatment approach is to first identify the health condition and then begin treatment. In this scenario, the physician discusses treatment options with the patient. The patient is free to decline treatment as they wish. If patients do nothing though, they will receive care.
For tobacco users, the default treatment is for them to "opt in" to receive smoking cessation assistance. The provider asks the smoker if they are ready to quit, and they offer medication and support only to those who respond back "yes". This limits the amount of smokers that receive treatment because only 1 in 3 smokers say they are ready to quit.
This study is looking at a novel approach to smoking cessation treatment. This study will compare the traditional, "standard of care" approach to opting in against a new approach where all smokers are provided with cessation medication and counseling unless they refuse it.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 4
Kontakter och platser
Studieorter
-
-
Kansas
-
Kansas City, Kansas, Förenta staterna, 66160
- University of Kansas Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Speak English or Spanish
- Have access to a telephone or mobile phone
- Not be currently pregnant or breast feeding
- Have no significant co-morbidity that precludes participation
- Current daily smoker
- Not in treatment for tobacco dependence
- Reside in Kansas or Missouri
Exclusion Criteria:
- Admission greater than 3 days
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Opt Out
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out".
Participant will receive a Opt Out treatment program.
Participants will receive counseling and nicotine replacement therapy.
|
Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants.
Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Andra namn:
Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Andra namn:
|
Aktiv komparator: Opt In
Traditional approach to tobacco treatment program.
Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program.
|
Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Andra namn:
Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Andra namn:
Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking.
For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
7-day Point-prevalence Abstinence
Tidsram: Month 1
|
7-day, self-reported and verified cigarette abstinence.
|
Month 1
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Treatment Engagement
Tidsram: Month 1
|
Percentages of participants who use cessation medications and participate in counseling post discharge
|
Month 1
|
Default-theory Based Measures
Tidsram: Month 1
|
We will assess the impact of opt-out versus opt-in treatment on perceived treatment coercion using items adapted from the Admission Experience Survey (AES) short form.
|
Month 1
|
7-day Point-prevalence Abstinence
Tidsram: Month 6
|
7-day, self-reported and verified cigarette abstinence.
|
Month 6
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Cost-effectiveness
Tidsram: Month 6
|
Counselor time, wage estimates, pharmacotherapy costs, and abstinence rates will be combined to report the incremental cost-effective ratio (ICER).
The ICER is the ratio of the difference in costs divided by the difference in effectiveness between the two study arms.
ICER indicates the added cost per additional quitter, a metric that will allow comparisons to other smoking cessation economic studies.
|
Month 6
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Kimber Richter, PhD, University of Kansas Medical Center
Publikationer och användbara länkar
Allmänna publikationer
- Faseru B, Mussulman LM, Nazir N, Ellerbeck EF, Shergina E, Scheuermann TS, Gajewski BJ, Catley D, Richter KP. Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment. Subst Abus. 2022;43(1):1035-1042. doi: 10.1080/08897077.2022.2060441.
- Faseru B, Ellerbeck EF, Catley D, Gajewski BJ, Scheuermann TS, Shireman TI, Mussulman LM, Nazir N, Bush T, Richter KP. Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial. Trials. 2017 Aug 14;18(1):379. doi: 10.1186/s13063-017-2119-9.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00001774
- R01HL131512 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Upphör med tobaksbruk
-
University of KonstanzAfrica Mental Health FoundationAvslutad
-
Eunice Kennedy Shriver National Institute of Child...AvslutadEnvironmental Tobacco Smoke (ETS)Förenta staterna
-
University of KonstanzAfrica Mental Health FoundationAvslutadPosttraumatisk stressyndrom | Khat Use DisorderKenya
Kliniska prövningar på Opt Out Treatment Program
-
University of PennsylvaniaAvslutadHypertoniFörenta staterna
-
University of OklahomaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes... och andra samarbetspartnersAvslutad
-
University of PennsylvaniaAvslutad
-
Johns Hopkins Bloomberg School of Public HealthMakerere University; Pontificia Universidad Javeriana; The Bloomberg Family...AvslutadIcke smittsamma sjukdomar | Enkäter och frågeformulärColombia, Uganda
-
Children's Hospital Medical Center, CincinnatiUniversity of UtahHar inte rekryterat ännuHIV-infektionerFörenta staterna
-
University of PennsylvaniaNational Institute on Aging (NIA)AvslutadHepatocellulärt karcinom | CirrosFörenta staterna
-
Duke UniversityAvslutad
-
University of OklahomaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)AvslutadHIV | AIDS | Fetalt alkoholsyndrom | Alkoholrelaterad neuroutvecklingsstörningFörenta staterna, Ryska Federationen
-
Oslo University HospitalUniversity of Oslo; Albert Einstein College of Medicine; University of Bergen och andra samarbetspartnersAvslutadLivmoderhalscancerNorge